In our bi-weekly feature, Meet AG Mednet, we get to know the people behind AG Mednet's Judi Collaboration Platform, which makes the world's clinical trials workflows, flow.

‍

Meet Mark Gee, Director of Client Engagement

What brought you to AG Mednet?

The opportunity to sell a technology that significantly improves the execution of clinical trials by connecting medical experts through a transparent platform.

‍
What do you like most about the company and your job?

All AG Mednet offerings are from “in-house” resources. Nothing is outsourced. My manager recognizes my industry experience so he gives me autonomy to perform my duties and he is always available when I need assistance.

‍
Mark Gee will be attending the 13th annual DPharm conference from September 20–22, 2023, at the Westin Copley Place in Boston, Massachusetts. When you see Mark, ask how AG Mednet's Judi Collaboration Platform embodies DPharm's spirit of disruptive innovation, and can support all your mission-critical clinical workflows, including adjudication, imaging, eligibility, site qualification, and more.

What’s on your headphones now—what music is on your playlist?

I don’t listen to music very often but when I do it’s usually just “white noise.”

Any career advice for people starting in this industry?

Work hard and demonstrate accountability for your success and the success of those around you.‍‍‍

‍

About Judi

AG Mednet is revolutionizing the clinical trial process through Judi, the innovative and award-winning clinical trial collaboration platform. Designed to empower the ecosystems that drive clinical research, Judi streamlines workflows, facilitates communication, and accelerates the development of novel therapies for patients. The proven Judi platform is trusted by 19 of the top 20 global biopharmaceutical sponsors and 5 of the top 6 global CROs. Additionally, the Judi platform enables clinical teams worldwide to come together seamlessly, ensuring the highest standards of data integrity and compliance.

‍